Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4083-4089. doi: 10.1080/21645515.2021.1956227. Epub 2021 Aug 10.
In response to the coronavirus disease 2019 (COVID-19) pandemic, many countries have implemented mitigating non-pharmaceutical interventions. We investigated the impact of these interventions and changes in public behavior on the incidences of selected vaccine-preventable diseases (VPDs) during the COVID-19 pandemic in the eastern of China.
From routine monitoring data collected in the capital of eastern China's Jiangsu Province, we extracted and analyzed the incidences of influenza; hand, foot and mouth disease (HFMD); varicella; mumps; pertussis; and hepatitis B. We also investigated the changes in public behavior during the COVID-19 pandemic through telephone interviews and questionnaire surveys.
Compared with the baseline (2017-2019), the incidences of all VPDs except influenza declined significantly in 2020 (HFMD decreased by 79.92%, varicella decreased by 7.71%, mumps decreased by 2.03%, pertussis decreased by 78.91%, and hepatitis B decreased by 0.31%). The reduction in reported cases in children (0-14 years) was greater than that in adults, and pertussis had the largest reduction (approximately 80%) in children. Influenza peaks in winter; in the three years before the COVID-19 pandemic, Influenza rates took an average of 10 weeks to recede to their lowest levels after the Spring Festival, while in 2020, this took only 1 week. A total of 366 outbreaks with 20,205 cases were reported during the COVID-19 pandemic. Among the participants in the study, 94.2% of the interviewees avoided going to high-risk areas, 82.4% avoided going to crowded places, 92.9% wore masks when going out,88.4% washed their hands frequently, and 67.9% maintained social distance.
Our study showed significant reductions in the incidences of VPDs after the implementation of a series of non-pharmaceutical interventions during the COVID-19 pandemic.
为应对 2019 年冠状病毒病(COVID-19)大流行,许多国家实施了缓解性非药物干预措施。我们调查了这些干预措施和公众行为的变化对中国东部 COVID-19 大流行期间某些疫苗可预防疾病(VPD)发病率的影响。
我们从中国东部江苏省省会的常规监测数据中提取并分析了流感、手足口病(HFMD)、水痘、腮腺炎、百日咳和乙型肝炎的发病率。我们还通过电话访谈和问卷调查调查了 COVID-19 大流行期间公众行为的变化。
与基线(2017-2019 年)相比,2020 年除流感外所有 VPD 的发病率均显著下降(HFMD 下降 79.92%,水痘下降 7.71%,腮腺炎下降 2.03%,百日咳下降 78.91%,乙型肝炎下降 0.31%)。儿童(0-14 岁)报告病例减少幅度大于成人,百日咳儿童减少幅度最大(约 80%)。流感在冬季达到高峰;在 COVID-19 大流行之前的三年中,流感发病率平均需要 10 周才能在春节后降至最低水平,而 2020 年仅需 1 周。COVID-19 大流行期间共报告 366 起暴发,20205 例。在研究参与者中,94.2%的受访者避免前往高风险地区,82.4%避免前往拥挤场所,92.9%外出时戴口罩,88.4%经常洗手,67.9%保持社交距离。
我们的研究表明,在 COVID-19 大流行期间实施了一系列非药物干预措施后,VPD 的发病率显著下降。